Efendi Hüsnü, Boz Cavit, Karabudak Rana
Department of Neurology, Kocaeli University School of Medicine, Kocaeli, Turkey.
Department of Neurology, Technical University, School of Medicine, Trabzon, Turkey.
Noro Psikiyatr Ars. 2018;55(Suppl 1):S10-S14. doi: 10.29399/npa.23164.
There are different decision-making models in medicine for treatment decisions. Shared decision-making model is the most appropriate and widely used model for chronic diseases like Multiple Sclerosis (MS). In this model, the decision making process like treatment options is being discussed step by step between patients and physicians. However, increasing treatment options and medication side effects make the decision-making process more difficult for physicians and reveal the need to share wider knowledge with the patient. In this article we evaluate treatment decision making in patients with MS involving real life experiences.
医学中有不同的决策模型用于治疗决策。共同决策模型是治疗像多发性硬化症(MS)这样的慢性病最合适且应用最广泛的模型。在该模型中,诸如治疗方案等决策过程会在患者和医生之间逐步讨论。然而,治疗方案的增加以及药物副作用使得医生的决策过程更加困难,也凸显了与患者分享更广泛知识的必要性。在本文中,我们评估了涉及现实生活经历的MS患者的治疗决策。